<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Weight Loss Drugs Give Restaurants a New Hurdle: Diners Who Eat Less — Live Feed</title><link>https://www.live-feeds.com/feed/weight-loss-drugs-give-restaurants-a-new-hurdle-diners-who-eat-less</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/weight-loss-drugs-give-restaurants-a-new-hurdle-diners-who-eat-less/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>GLP-1 Weight Loss Drugs Trigger Restaurant Sales Slump and Menu Overhauls</title><link>https://www.live-feeds.com/feed/weight-loss-drugs-give-restaurants-a-new-hurdle-diners-who-eat-less</link><guid isPermaLink="false">https://www.live-feeds.com/feed/weight-loss-drugs-give-restaurants-a-new-hurdle-diners-who-eat-less#u103454</guid><pubDate>Mon, 05 Oct 2026 18:02:04 +0000</pubDate><description>Restaurants are facing a sales slump as GLP-1 weight-loss medications curb diner appetites, leading to fewer orders and smaller portions. Gallup polling indicates 11% of U.S. adults now use these drugs, up from 3% in 2024. In response, McDonald&amp;#039;s is spending $8.5 billion to overhaul its menu to target GLP-1 users and protein-maxxing trends. This shift has created a financial squeeze for establishments of all sizes, as they grapple with declining consumption patterns and rising operational costs.Why it mattersGLP-1 medications reduce hunger and cravings, changing how consumers interact wit</description></item>
</channel></rss>